NPC1L1 and inflammatory bowel disease: In conclusion, the increased genetic expression in HMGCR inhibitor targets (gene: HMGCR) may lower the risk of IBD and CD, whereas genetic variation in NPC1L1 targets (gene: NPC1L1) expression showed a positive correlation with IBD.